Form 4 · Filed May 1, 2026, 12:00 PM UTC
SYRE/Spyre Therapeutics, Inc.
Sloan Sheldon — Chief Medical Officer
Pro feature
Read the AI thesis behind every Form 4 — only on Pro and Premium
Free accounts see filings 24 hours late and the thesis is hidden until then. Upgrade to read every Form 4 the moment it hits EDGAR, with a Sonnet-4.6 (or Opus-4.7 on flagged buys) thesis attached.
Free
FreeBrowse the last 30 days of insider filings. Weekly digest by email.
- · Last 30 days of filings (list view)
- · Conviction score badge on each filing
- · Insider profiles & edge scores
Pro
$15/moAI thesis on every filing + watchlist email alerts.
- · Full AI thesis on every Form 4 (Sonnet 4.6)
- · Full filing history (no 30-day cap)
- · Unlimited ticker watchlists
Premium
$49/moOpus 4.7 deep theses + SMS alerts + cluster-buy detection.
- · Everything in Pro
- · Opus-grade thesis on flagged buys
- · SMS alerts for highest-conviction filings
Transactions
9 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 1, 2026 | M | other | 78,333 | $27 | $2,151,024 | 78,333 |
| May 1, 2026 | S | sell | 21,306 | $70 | $1,481,406 | 57,027 |
| May 1, 2026 | S | sell | 19,656 | $71 | $1,387,910 | 37,371 |
| May 1, 2026 | S | sell | 8,777 | $72 | $628,082 | 28,594 |
| May 1, 2026 | S | sell | 12,777 | $73 | $931,954 | 15,817 |
| May 1, 2026 | S | sell | 10,358 | $74 | $763,799 | 5,459 |
| May 1, 2026 | S | sell | 5,059 | $75 | $377,401 | 400 |
| May 1, 2026 | S | sell | 400 | $75 | $30,148 | 0 |
| May 1, 2026 | M | other | 78,333 | $0 | — | 321,667 |
Source: SEC EDGAR raw filing ↗ · Accession 0002038798-26-000004